126 - What’s New in Respiratory Viruses?

Speaker(s)

• CC

  Charles Chiu, MD, PhD

  Professor
  Labratory Medicine
  UCSF
  San Francisco, California

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Tina Hartert, MD, MPH

  Professor of Medicine
  Vanderbilt University School of Medicine
  Nashville, Tennessee

  Disclosure: Pfizer : Advisor or Review Panel member (Status: Terminated --- 05/2020); Sanofi-Aventis : Advisor or Review Panel member (Status: Terminated --- 04/2020)
• 

  John Williams, MD

  Professor and Chief; Director, Institute of Infection, Inflammation, and Immunity in Children (i4Kids)
  Univ of Pittsburgh/ UPMC Children's Hospital of Pittsburgh
  Pittsburgh, PA

  Disclosure: GlaxoSmithKline () : Advisor or Review Panel member; IDConnect () : Advisor or Review Panel member; Quidel () : Advisor or Review Panel member

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit

No CPE Credits

Learning Objectives:

• discuss the connection between respiratory viruses and asthma
• describe the impact of human metapneumovirus infections among special populations and adults
• describe pathogen discovery methods to find new viruses

Presentations:

• 10:00am – 11:15am EDT

  A Wolf Among Sheep: Human Metapneumovirus Among Adults and Special Populations
  John V. Williams, MD – Univ of Pittsburgh/ UPMC Children's Hospital of Pittsburgh
• 10:00am – 11:15am EDT

  Impact of Respiratory Syncytial Virus on Asthma
  Tina Hartert, MD, MPH – Vanderbilt University School of Medicine
• 10:00am – 11:15am EDT

  Using Pathogen Discovery Methods to Discover the Next Respiratory Viruses
  Charles Chiu, MD, PhD – UCSF